Please find enclosed Un-Audited Financial Results for the quarter ended 30th June 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Boston Bio Systems Limited reported unaudited financial results for Q1 FY26 (quarter ended 30 June 2025) with revenue from operations of Rs. 18.05 lakhs and a profit after tax of Rs. 4.01 lakhs, a notable turnaround from the full-year FY25 loss of Rs. (54.73) lakhs. The company also appointed Mr. Shashank Kumar as Secretarial Auditor and Mr. Nishant Sharma as Internal Auditor for FY25. Additionally, the Board approved a proposed change of the company's name from 'Boston Bio Systems Limited' to 'Boston Commerce Limited', subject to shareholder and regulatory approvals. The statutory auditor (CA Vishal Nahar) issued an unqualified limited review report on the quarterly results.
The Q1 FY26 return to profit is a positive signal after a loss-making FY25, though the absolute numbers remain small relative to the paid-up equity of Rs. 700.22 lakhs. Shareholders should watch for shareholder approval on the proposed name change to Boston Commerce Limited, which may signal a shift in business focus.